Management and treatment outcomes of tuberculous patients, eastern Paris, France, 2004

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 7, 2009, Pages 881-887

  Valin, Nadia ^a,f   Hejblum, G ^b,c   Borget, I ^b   Mallet, H P ^d   Antoun, F ^d   Che, D ^e   Chouaid, C ^a,b  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d Cellule Tuberculose   (France)

^e INSTITUT DE VEILLE SANITAIRE   (France)

^f Service des Maladies Infectieuses   (France)

Author keywords

Health system; Management; Treatment outcome; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SOCIOECONOMICS; SPUTUM ANALYSIS; SUBSTANCE ABUSE; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PARIS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 67651225655     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Che D, Cailhol J, Campese C, Decludt B. Epidemiology of tuberculosis in Ile-de-France in 2001. Rev Mal Respir 2004; 21: 272-278.
2. Che D, Bitar D. Les cas de tuberculoses déclarés en France en 2004. Bull Epidemiol Hebd 2007; 11: 85-89.
3. Veen J, Raviglione M, Rieder H L, et al. Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J 1998; 12: 505-510. (Pubitemid 28389555)
4. Bruhl D L, Paty M C, Antoine D, Bessette D. Recent changes in tuberculosis control and BCG vaccination policy in France. Euro Surveill 2007; 12: E070913.3.
5. Farge D, Porcher R, Antoun F, et al. TB-INFO Association. Tuberculosis in European cities: establishment of a patient monitoring system over 10 years in Paris, France. Int J Tuberc Lung Dis 2007; 11: 992-998. (Pubitemid 47425026)
6. Blumberg H M, Burman W J, Chaisson R E, et al., American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662.
7. Antoun F, Momas I, Vieu V, Poinsard R, Crespy M. Suivi épidémiologique des cas de tuberculose dans les centres médicosociaux de Paris pour l'année 1994. Rev Mal Respir 1998; 15: 171-176.
8. Stop TB Partnership and World Health Organization. Global Plan to Stop TB 2006-2015. Geneva, Switzerland: WHO, 2006.
9. EuroTB and the national coordinators for tuberculosis surveillance in the WHO European region. Surveillance of tuberculosis in Europe. Report on cases of tuberculosis notified in 2003. Saint Maurice, France: Institut de Veille Sanitaire, 2005.
10. Faustini A, Hall A J, Perucci C A. Tuberculosis treatment outcomes in Europe: a systematic review. Eur Respir J 2005; 26: 503-510. (Pubitemid 41264216)
11. Falzon D, Le Strat Y, Belghiti F, Infuso A; EuroTB Correspondents. Exploring the determinants of treatment success for tuberculosis cases in Europe. Int J Tuberc Lung Dis 2005; 9: 1224-1229. (Pubitemid 41735601)
12. Falzon D, Scholten J, Infuso A. Tuberculosis outcome monitoring - is it time to update European recommendations? Euro Surveill 2006; 11: 20-25.
13. Diel R, Niemann S. Outcome of tuberculosis treatment in Hamburg: a survey, 1997-2001. Int J Tuberc Lung Dis 2003; 7: 124-131.
14. Cator M, Brassard P, Ducic S, Culman K. Factors related to non-compliance with active tuberculosis treatment in Montreal 1992-1995. Can J Public Health 2002; 93: 92-97.
15. Antoine D, French C E, Jones J, Watson J M. Tuberculosis treatment outcome monitoring in England, Wales and Northern Ireland for cases reported in 2001. J Epidemiol Community Health 2007; 61: 302-307.
16. Bayer R, Stayton C, Desvarieux M, Healton C, Landesman S, Tsai W Y. Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary? Am J Public Health 1998; 88: 1052-1058.
17. Dautzenberg B, Perronne C, Haury B. Délais de mise sous traitement des tuberculeux en France en septembre 1994. Med Mal Infect 1995; 25: 337-342.
18. Tattevin P, Chapplain J M, Lesprit P, et al. Tuberculosis treatment duration in France: from guidelines to daily practice. Eur J Intern Med 2006; 17: 427-429. (Pubitemid 44572145)
19. Sumartojo E M, Geiter L J, Miller B, Hale B E. Can physicians treat tuberculosis? Report on a national survey of physician practices. Am J Public Health 1997; 87: 2008-2011. (Pubitemid 28055921)
20. Vasankari T, Holmström P, Ollgren J, Liippo K, Kokki M, Ruutu P. Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. BMC Public Health 2007; 7: 291. (Pubitemid 350198370)
21. Dean G L, Edwards S G, Ives N J, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 2002; 16: 75-83. (Pubitemid 34062184)
22. Nahid P, Gonzalez L C, Rudoy I, et al. Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med 2007; 175: 1199-1206. (Pubitemid 46855463)